Jpmorgan Chase & CO Amphastar Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 66,880 shares of AMPH stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,880

Previous 153,571 56.45%

Holding current value

$1.57 Million

Previous $5.7 Million 66.01%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$26.24 - $38.48 $2.27 Million - $3.34 Million	-86,691 Reduced 56.45%	66,880 $1.94 Million
Q4 2024 Feb 12, 2025	BUY	$36.84 - $53.4 $2.93 Million - $4.25 Million	79,651 Added 107.75%	153,571 $5.7 Million
Q3 2024 Dec 26, 2024	BUY	$36.99 - $50.09 $86,889 - $117,661	2,349 Added 3.28%	73,920 $3.59 Million
Q3 2024 Nov 08, 2024	BUY	$36.99 - $50.09 $86,889 - $117,661	2,349 Added 3.28%	73,920 $3.59 Million
Q2 2024 Dec 26, 2024	SELL	$38.65 - $43.48 $90,788 - $102,134	-2,349 Reduced 3.18%	71,571 $2.86 Million
Q2 2024 Aug 12, 2024	SELL	$38.65 - $43.48 $2.66 Million - $3 Million	-68,883 Reduced 49.04%	71,571 $2.86 Million
Q1 2024 Dec 26, 2024	BUY	$42.85 - $63.45 $2.85 Million - $4.22 Million	66,534 Added 90.01%	140,454 $6.17 Million
Q1 2024 May 10, 2024	BUY	$42.85 - $63.45 $2.84 Million - $4.2 Million	66,229 Added 89.23%	140,454 $6.17 Million
Q4 2023 Dec 26, 2024	BUY	$44.49 - $62.93 $13,569 - $19,193	305 Added 0.41%	74,225 $4.59 Million
Q4 2023 Feb 12, 2024	SELL	$44.49 - $62.93 $281,354 - $397,969	-6,324 Reduced 7.85%	74,225 $4.59 Million
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $150,137 - $214,435	-3,299 Reduced 3.93%	80,549 $3.7 Million
Q2 2023 Aug 11, 2023	SELL	$35.77 - $58.38 $1.21 Million - $1.98 Million	-33,919 Reduced 28.8%	83,848 $4.82 Million
Q1 2023 May 18, 2023	BUY	$27.99 - $37.92 $1.34 Million - $1.81 Million	47,801 Added 68.32%	117,767 $4.42 Million
Q1 2023 May 11, 2023	SELL	$27.99 - $37.92 $1.23 Million - $1.66 Million	-43,787 Reduced 38.49%	69,966 $2.62 Million
Q4 2022 Feb 13, 2023	SELL	$27.93 - $31.27 $2.96 Million - $3.31 Million	-105,930 Reduced 48.22%	113,753 $3.19 Million
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $69,644 - $95,394	2,527 Added 1.16%	219,683 $6.17 Million
Q2 2022 Aug 11, 2022	BUY	$29.79 - $42.29 $3.83 Million - $5.44 Million	128,688 Added 145.46%	217,156 $7.56 Million
Q1 2022 May 11, 2022	SELL	$22.96 - $36.45 $506,199 - $803,613	-22,047 Reduced 19.95%	88,468 $3.18 Million
Q4 2021 Feb 10, 2022	SELL	$18.14 - $23.29 $1.15 Million - $1.47 Million	-63,175 Reduced 36.37%	110,515 $2.57 Million
Q3 2021 Nov 12, 2021	BUY	$17.83 - $21.49 $3.1 Million - $3.73 Million	173,690 New	173,690 $3.3 Million

Others Institutions Holding AMPH

# of Institutions

256

Shares Held

33.3M

Call Options Held

18.3K

Put Options Held

12.6K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.15B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Amphastar Pharmaceuticals, Inc. Transaction History